Remiges Ventures
Overview
Remiges Ventures is a venture capital firm that focuses on groups and businesses in the Japanese academia and pharmaceutical industry.
Investment Focus
- Early-stage drug discovery ventures developing advanced drugs
- Innovative assets from Japanese academic institutions
- Global investment opportunities in the life sciences sector
Portfolio Companies
Reach Remiges Ventures directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Remiges Ventures
What sectors does Remiges Ventures invest in?
Remiges Ventures invests in Healthcare, Life Sciences, Pharmaceuticals, Medical Devices and Biotechnology, and is based in Cambridge, Massachusetts, United States. Remiges Ventures is listed as a venture capital in the ConnectSafely investor database.
What stage does Remiges Ventures invest at?
Remiges Ventures backs companies at Seed, Early Stage, Series A and Series B.
Which regions does Remiges Ventures invest in?
Remiges Ventures invests across United States, Japan, Europe and Israel.
Who are the partners at Remiges Ventures?
Team members listed for Remiges Ventures include Hiroshi Tamada (Chief Medical Officer) and Taro Inaba (Managing Partner).
What companies has Remiges Ventures invested in?
Remiges Ventures's portfolio includes Restore Vision, InFlectis BioScience, KisoJi Biotechnology and Qinotto.
How do I contact Remiges Ventures?
Remiges Ventures's contact details are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
